Procalcitonin Level and Kinetics in Children With Bacterial Infections

This study has been completed.
Information provided by:
Shaare Zedek Medical Center Identifier:
First received: July 9, 2008
Last updated: May 17, 2011
Last verified: January 2009

The purposes of this study are:

  1. To determine whether procalcitonin level at admission of pediatric patients with bacterial infections can be used as a marker for prediction of defervescence and hospitalization length
  2. To examine the kinetics of procalcitonin in pediatric patients with bacterial infections and persistent fever

Bacterial Infections
Urinary Tract Infection
Lobar Pneumonia
Septic Arthritis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Procalcitonin Level as a Prognostic Marker and Its' Kinetics in Children With Bacterial Infections

Resource links provided by NLM:

Further study details as provided by Shaare Zedek Medical Center:

Primary Outcome Measures:
  • time to defervescence [ Time Frame: discharge ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • length of hospitalization [ Time Frame: discharge ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

whole blood

Estimated Enrollment: 50
Study Start Date: August 2008
children with proven of probable invasive bacterial infections


Ages Eligible for Study:   up to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

hospitalized patients at date of admission


Inclusion Criteria:

  • Positive blood, urine, synovial, bone, pleural effusion, abscess or CSF culture
  • Cellulitis, lobar pneumonia, osteomyelitis,
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00714402

Shaare Zedek Medical Center
Jerusalem, Pob 3235, Israel, 91031
Sponsors and Collaborators
Shaare Zedek Medical Center
Principal Investigator: Yechiel Schlesinger, MD Shaare Zedek Medical Center
  More Information


Responsible Party: Yechiel Schlesinger, Shaare Zedek Medical Center Identifier: NCT00714402     History of Changes
Other Study ID Numbers: pct.ctil
Study First Received: July 9, 2008
Last Updated: May 17, 2011
Health Authority: Israel: Helsinki committee

Keywords provided by Shaare Zedek Medical Center:

Additional relevant MeSH terms:
Bacterial Infections
Urinary Tract Infections
Urologic Diseases processed this record on March 26, 2015